Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety of pitolisant in narcolepsy (12‑month open-label follow-up)
2010-023804-28Phase 3Completed
- Sponsor
- Bioprojet
- Start
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of pitolisant in narcolepsy and narcolepsy type 1 (NT1), sponsored by Bioprojet. Primary endpoint: Long-term safety (adverse events incidence). Started Jun 2011; status: completed.
02
Drugs
pitolisant
03
Conditions
narcolepsynarcolepsy type 1 (NT1)
Beyond the preview
Go deeper on 2010-023804-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023804-28.